All Columns articles – Page 64
-
Opinion
Be careful what you wish for
The struggle for a single unitary European patent may be close to an end, says Darren Smyth, but we must still hold out for an agreement that performs as it should
-
Opinion
The complex paradox of science
Science can provide solutions for society, says Rutger van Santen, but only if it is given the freedom to find the unexpected
-
Opinion
Indoxamycin B
It has always been the rearrangement reactions that did their best to elude my eye
-
-
Opinion
Letters: April 2012
As an affiliate member of the Natural Environment Research Council’s (NERC’s) peer review college, I would like to comment on the article about NERC’s intention to reduce the number of uncompetitive proposals submitted for funding (Chemistry World, March 2012, p17). For several years, I have helped in ...
-
Opinion
Letters: March 2012
The article ’Silver soils’ (Chemistry World, February 2012, p36) highlights some interesting recent events relating to the environmental impact of silver residues. While a wealth of evidence exists to show that silver ions are toxic to lower organisms, there is less evidence that nanocrystalline or other forms of silver present ...
-
-
Opinion
Skin deep science
Philip Ball takes a critical look at the science behind an anti-ageing cream and discovers there's some truth in its sugar-coated claims
-
OpinionThe elements of drug design
Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love
-
Opinion
Scholarisine A
Ring strain is a fascinating phenomenon - one that is best understood with plastic modelling kits, wearing safety specs for ring sizes of four or less. These smaller rings are packed with energy, resulting from both tight bond angles (deviating from the tetrahedral ideal of 109.5?), and ...
-
Opinion
Letters: February 2012
In his comment article, David Fox (Chemistry World, January 2012, p42) highlights the importance of having access to a well-curated repository of small molecules for drug discovery (and chemical genomics), but he feels that it is important to ’combine a well-validated target with a means of intervention that minimises attrition ...